Vyjuvek

Krystal's Vyjuvek Gene Therapy Receives FDA Approval, Boosts Sales Forecast

Krystal’s Vyjuvek Gene Therapy Gains FDA Approval, Spurs Sales Projections

Anika Sharma

Krystal Biotech’s CEO, Krish Krishnan, was quick to highlight in the company’s inaugural conference call to present its quarterly results ...

Krystal Biotech, Priority Review Voucher, Vyjuvek, Beremagene geperpavec-svdt, Rare Pediatric Disease

Krystal Biotech Secures $100 Million in Sale of Priority Review Voucher

Anika Sharma

Krystal Biotech proudly announces the successful transaction of its Rare Pediatric Disease Priority Review Voucher (PRV), yielding an impressive $100 ...